RSS feeds
Get topic alerts directly to your email inbox
Here’s an easy way to receive the latest news related to your topic(s) of choice as soon as the articles are published.
1. Copy a url for a topic from the list below.
2. In Outlook, right-click the RSS feeds folder and choose Add a New RSS Feed.
3. Paste the url.
4. Choose Add > OK.
5. Suggestion: Create a subfolder for your topic and an associated rule so they alerts are moved directly into your folder of choice.
Alternately, you may use the same links in any RSS reader application such as Feedly or Innoreader.
Topics
| Aesthetics https://www.bioworld.com/rss/topic/237-aesthetics |
| Aging https://www.bioworld.com/rss/topic/566-aging |
| Analysis and data insight https://www.bioworld.com/rss/topic/109-analysis-and-data-insight |
| Anesthesiology https://www.bioworld.com/rss/topic/238-anesthesiology |
| Artificial intelligence https://www.bioworld.com/rss/5 |
| Asia-Pacific — Includes Asia-Pacific, Australia, China, Japan
https://www.bioworld.com/rss/23 |
| Australia — Includes Australia, TGA https://www.bioworld.com/rss/26 |
| Biomarkers https://www.bioworld.com/rss/topic/543-biomarkers |
| Briefs — Includes appointments and advancements, briefs, deals and M&A, earnings, in the clinic, other news to note, post market, preclinical, products regulatory, products clinical, regulatory actions, regulatory front, stock https://www.bioworld.com/rss/11 |
| Canada — Includes Canada, Health Canada
https://www.bioworld.com/rss/27 |
| Cancer — Includes cancer, oncology https://www.bioworld.com/rss/15 |
| CAR T — Includes CAR T (Cell therapy), CAR T (Gene therapy), CAR T (Immunotherapy) https://www.bioworld.com/rss/8 |
| Cardiovascular https://www.bioworld.com/rss/topic/240-cardiovascular |
| Cell therapy https://www.bioworld.com/rss/6 |
| China — Includes China, NMPA https://www.bioworld.com/rss/28 |
| Clinical — Clinical, in the clinic, products clinical https://www.bioworld.com/rss/12 |
| Coronavirus https://www.bioworld.com/rss/topic/517-coronavirus |
| Deals and M&A — Includes acquisition, asset purchase, collaboration, co-promotion, deals and M&A, deals and M&A (briefs), development, distribution, equity option, government supply contract, grant, joint venture, license, merger, non-profit, research, research only, reverse merger, royalty buyout, service agreement, settlement, spinout, supply only https://www.bioworld.com/rss/14 |
| Dental https://www.bioworld.com/rss/topic/241-dental |
| Dermatologic https://www.bioworld.com/rss/topic/242-dermatologic |
| Diagnostics — Includes artificial intelligence (Diagnostics), biopsy, diagnostics, electrocardiogram, genomics, imaging, liquid biopsy, monitoring, point-of-care https://www.bioworld.com/rss/21 |
| Digital health — Includes algorithm, artificial intelligence, cloud-based platform, cybersecurity, database, digital health, electronic health record, mobile/smartphone app, SAAS, SAMD, software, telehealth https://www.bioworld.com/rss/22 |
| Drug design, drug delivery and technologies https://www.bioworld.com/rss/topic/544-drug-design-drug-delivery-and-technologies |
| Drug resistance https://www.bioworld.com/rss/topic/117-drug-resistance |
| Drugs — Includes antibiotic, antibody, antibody-drug conjugate, antigen, antisense, biosimilar, bispecific antibody, CAR T, cell therapy, drugs, enzyme, gene therapy, generic, immuno-oncology, microbiome, monoclonal antibody, nanotech, natural, oncolytic, peptide, plasma, protein, RNAi, small molecule, vaccine https://www.bioworld.com/rss/18 |
| Ear, nose and throat https://www.bioworld.com/rss/topic/245-ear-nose-and-throat |
| EMA https://www.bioworld.com/rss/topic/430-ema |
| Endocrine/metabolic — Includes diabetes, endocrine/metabolic, obesity https://www.bioworld.com/rss/16 |
| Europe — Includes EMA, Europe, MHRA https://www.bioworld.com/rss/29 |
| FDA https://www.bioworld.com/rss/topic/433-fda |
| Financings — Includes American depositary shares, at-the-market offering, bought deal offering, credit facility, investment, financings, follow-on, IPO, grant, loan, mezzanine, notes offering, PIPE (private investment of public equity), private, private placement, public, registered direct offering, seed, series A, series B, series C, series D, series E, series F, series G, share issue, warrant exercise https://www.bioworld.com/rss/19 |
| Gastrointestinal https://www.bioworld.com/rss/topic/247-gastrointestinal |
| Gene therapy https://www.bioworld.com/rss/7 |
| Genetic/congenital https://www.bioworld.com/rss/topic/548-genetic-congenital |
| Genitourinary/sexual function https://www.bioworld.com/rss/topic/248-genitourinary-sexual-function |
| Gynecology/Obstetrics https://www.bioworld.com/rss/topic/258-gynecology-obstetrics |
| Health Canada https://www.bioworld.com/rss/topic/439-health-canada |
| Hematologic https://www.bioworld.com/rss/topic/249-hematologic |
| HIV/AIDS https://www.bioworld.com/rss/topic/542-hiv-aids |
| Immune https://www.bioworld.com/rss/topic/250-immune |
| Immuno-oncology https://www.bioworld.com/rss/topic/280-immuno-oncology |
| Infection https://www.bioworld.com/rss/topic/251-infection |
| Inflammatory https://www.bioworld.com/rss/topic/252-inflammatory |
| Japan https://www.bioworld.com/rss/30 |
| Latin America https://www.bioworld.com/rss/topic/397-latin-america |
| Medical devices and technologies — Includes sub-topics ranging from artificial intelligence to robotic surgery https://www.bioworld.com/rss/20 |
| Ministry of Health, Labour and Welfare https://www.bioworld.com/rss/topic/460-mhlw |
| Medicines and Healthcare products Regulatory Agency https://www.bioworld.com/rss/topic/458-mhra |
| Microbiome https://www.bioworld.com/rss/9 |
| Middle East North Africa https://www.bioworld.com/rss/topic/398-middle-east-north-africa |
| Musculoskeletal https://www.bioworld.com/rss/topic/253-musculoskeletal |
| Neonatal/pediatrics https://www.bioworld.com/rss/topic/254-neonatal-pediatrics |
| Nephrology https://www.bioworld.com/rss/topic/255-nephrology |
| Neurology/psychiatric https://www.bioworld.com/rss/topic/256-neurology-psychiatric |
| New compound https://www.bioworld.com/rss/topic/546-new-compound |
| Newco news — Feature articles on newly emerging companies https://www.bioworld.com/rss/topic/391-newco-news |
| National Medical Products Administration https://www.bioworld.com/rss/topic/556-nmpa |
| Ocular — Includes ocular, ophthalmic https://www.bioworld.com/rss/17 |
| Omics — Includes genomics, GWAS, metabolomics, omics, proteomics https://www.bioworld.com/rss/10 |
| Orthopedics (medtech) https://www.bioworld.com/rss/topic/262-orthopedics |
| Policy https://www.bioworld.com/rss/topic/575-policy |
| Regulatory — Includes coverage of top regulatory news from global regulatory agencies https://www.bioworld.com/rss/24 |
| Respiratory https://www.bioworld.com/rss/topic/263-respiratory |
| Substance use and poisoning https://www.bioworld.com/rss/topic/545-substance-use-and-poisoning |
| Therapeutic Goods Administration https://www.bioworld.com/rss/topic/488-tga |
| Toxicity/intoxication https://www.bioworld.com/rss/topic/264-toxicity-intoxication |
| U.S. — Includes 510(k), CDRH, Central Drugs Standard Control Organization, CMS, FDA, FTC, NIH, orange book, PDUFA, SEC, U.S. https://www.bioworld.com/rss/31 |
| Urology https://www.bioworld.com/rss/topic/265-urology |
| Women's health— Includes gynecology/obstetrics, women's health https://www.bioworld.com/rss/32 |